Colistin (Polymyxin E)

What is Colistin (Polymyxin E)?

Colistin, also called polymyxin E, is an old antibiotic that has come back into use as a last resort. It is FDA-approved and has been around for decades, but its toxicity pushed it aside until the rise of multidrug-resistant bacteria left doctors with few alternatives. It is important to be clear up front: this is a serious hospital antibiotic, not a wellness or performance peptide, and it does not belong in a self-administration context.

How Colistin (Polymyxin E) works

Colistin is a cyclic polypeptide that targets the outer membrane of Gram-negative bacteria. It binds lipopolysaccharide in that membrane, disrupts its integrity, and causes the bacterial cell to leak and die. This membrane-disrupting action is potent against otherwise untreatable organisms, but it is not perfectly selective, which is part of why it can harm human tissue as well.

What the research shows

Colistin is genuinely established in clinical medicine, with an extensive literature and real use against carbapenem-resistant infections when other antibiotics fail. It was used against a meaningful share of the most resistant infections in recent years. The research story is less about proving it works and more about managing its toxicity and dosing so it can be used safely, because its narrow safety margin is the central challenge.

Dosage and how it is used

Colistin is dosed in hospital settings, given intravenously or by inhalation, with dosing carefully calculated and kidney function monitored throughout. Optimal dosing is an active area of clinical guidance precisely because the toxic and therapeutic ranges are close together. There is no self-use protocol, and there should not be one.

→ How to reconstitute Colistin (Polymyxin E): calculator, units to draw & storage

Side effects and safety

The defining safety issues are nephrotoxicity and neurotoxicity. Kidney injury is common enough that it frequently forces dose reductions or stopping treatment, and in some studies a large majority of patients developed some degree of kidney damage. Neurological effects can also occur. This is medicine used under close supervision when the alternative is an untreatable infection.

• Research depth: extensive clinical use. FDA-approved, hospital-administered antibiotic.
• High risk of kidney and nerve toxicity; narrow safety margin.
• Not a self-use compound under any circumstances. Administered and monitored by clinicians.

Frequently asked questions

References

• Colistin and its role in the era of antibiotic resistance: an extended review. PMC.
• Molecular Mechanisms of Colistin-Induced Nephrotoxicity. PMC.